Mannatech (NASDAQ:MTEX) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Friday morning. The firm issued a buy rating on the stock.

Mannatech Price Performance

Shares of MTEX stock opened at $7.52 on Friday. The stock has a 50 day moving average price of $7.58 and a 200 day moving average price of $7.56. Mannatech has a 52-week low of $6.75 and a 52-week high of $10.51. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. The firm has a market capitalization of $14.14 million, a P/E ratio of -11.94 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last issued its earnings results on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The company had revenue of $27.74 million during the quarter.

Insiders Place Their Bets

In related news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now owns 54,721 shares of the company’s stock, valued at $424,087.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 41.50% of the stock is owned by company insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.